🧵 1. Valiant Labs shares list at 15.82% premium over IPO price, giving investors a profit of Rs 22.15 per share on debut. #business
🧵 1. Valiant Labs shares list at 15.82% premium over IPO price, giving investors a profit of Rs 22.15 per share on debut. #business
🧵 3. Valiant Labs shares' GMP rose 14.29% before listing. Shareholders advised to book profits, but long-term holders can set stop loss at Rs 150.
🧵 5. Valiant Labs IPO receives Rs 45.74 Crore from anchor investors ahead of public issue. Minimum lot size is 105 shares, retail investment at Rs 14,700.
🧵 Read more at: https://www.financialexpress.com/market/valiant-laboratories-sees-strong-debut-lists-over-16-premium-on-bourses-should-you-hold-or-book-profit-3264588/
🧵 4. Valiant Labs is an API and Bulk Drug manufacturer specializing in Paracetamol. Sustained revenue growth of 35.3% during FY21-23.
🧵 2. Valiant Labs IPO subscribed 29.76 times, indicating positive response from investors. Consider company's risks before investing.